Targeting inflamed tissues with nanoparticles can be achieved through various mechanisms:
Passive targeting: Leveraging the enhanced permeability and retention (EPR) effect, nanoparticles can accumulate in inflamed tissues due to leaky vasculature. Active targeting: Functionalizing nanoparticles with ligands or antibodies that bind specifically to receptors on inflamed cells.
